Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2017-01-01Pilot of a computerised antithrombotic risk assessment tool version 2 (CARATV2.0) for stroke prevention in atrial fibrillationWang, Y; Bajorek, B
2014-01-01New oral anticoagulants in practice: Pharmacological and practical considerationsWang, Y; Bajorek, B
2018-09-01Selecting antithrombotic therapy for stroke prevention in atrial fibrillation: Health professionals’ feedback on a decision support toolWang, Y; Bajorek, B
2014-01-01Safe use of antithrombotics for stroke prevention in atrial fibrillation: Consideration of risk assessment tools to support decision-makingWang, Y; Bajorek, B
2016-04-01Old age, high risk medication, polypharmacy: A ‘trilogy’ of risks in older patients with atrial fibrillationWang, Y; Singh, S; Bajorek, B
-Loss of Hyaluronan and Proteoglycan Link Protein-1 Induces Tumorigenesis in Colorectal CancerWang, Y; Xu, X; Marshall, JE; Gong, M; Zhao, Y; Dua, K; Hansbro, PM; Xu, J; Liu, G
2016-12-01Clinical pre-test of a computerised antithrombotic risk assessment tool for stroke prevention in atrial fibrillation patients: giving consideration to NOACsWang, Y; Bajorek, B
2018-01-01Impact of a computerized antithrombotic risk assessment tool on the prescription of thromboprophylaxis in Atrial Fibrillation: Hospital SettingPandya, E; Masood, N; Wang, Y; Krass, I; Bajorek, B
2018-02-01Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital settingPandya, EY; Anderson, E; Chow, C; Wang, Y; Bajorek, B
Results 1-9 of 9 (Search time: 0.024 seconds).
  • previous
  • 1
  • next